• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.66% Nasdaq Up0.22%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    18.37 Down 0.55(2.91%) 1:14PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.3
    Mean Recommendation (last week):1.3
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:33.11
    Median Target:33.00
    High Target:45.00
    Low Target:24.00
    No. of Brokers:9

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Apr 4, 2012Cantor FitzgeraldInitiated Buy
    May 17, 2011OppenheimerInitiated Outperform
    Oct 1, 2010WedbushInitiated Outperform
    Feb 25, 2010Roth CapitalInitiated Buy
    Sep 29, 2009WBB SecuritiesInitiated Strong Buy
    Dec 19, 2008NeedhamDowngradeBuyHold
    Oct 24, 2008Merriman Curhan FordInitiated Buy
    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0777
    Buy0332
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.